Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Recurrent thrombosis and miscarriages are the main clinical manifestations of
antiphospholipid syndrome (APS). Although most patients display both clinical signs, some …

Abstract Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies are often detected in
patients with antiphospholipid syndrome (APS), but how aPS/PT engage prothrombin at the …

Background There is no agreement on the prevalence of anti-phospholipid antibodies
(aPLs) and the correlation with atherosclerosis and cardiovascular (CV) events in the …

As the clinical symptoms of the antiphospholipid syndrome (APS) frequently occur
irrespective of the syndrome, diagnosis predominantly depends on the laboratory assays …

Objective Determination of lupus anticoagulants (LA) is an important, but still challenging
test in the diagnosis of antiphospholipid syndrome (APS). This is especially the case in …

Background Anticardiolipin (aCL) and anti‐β2 glycoprotein I (aβ2GPI) immunoglobulin (Ig)
G/IgM antibodies are 2 of the 3 laboratory criteria for classification of antiphospholipid …

Diagnosis of antiphospholipid syndrome (APS) lies in the recognition of antiphospholipid
antibodies (aPL). As standardization of tests for the detection of aPL is far from being optimal …

Objectives To assess the limitations of the SLICC (Systemic Lupus International
Collaborating Clinics) classification criteria for systemic lupus erythematosus (SLE), in …

Antiphospholipid syndrome (APS) was first identified as a distinct syndrome in the early
1980s in patients suffering from lupus with antiphospholipid antibodies (aPL), repeated …